Kura Oncology (KURA) Reports In-Line Q1 EPS

Kura Oncology (NASDAQ: KURA) reported Q1 EPS of ($0.83), in-line with the analyst estimate of ($0.83). Revenue for the quarter came in at $18.27 million versus the consensus estimate of $25.4 million.

For earnings history and earnings-related data on Kura Oncology (KURA) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Invesco Mortgage Capital declares $0.12 monthly dividend for June 2026
• Frequency Electronics secures $10 million credit facility with JPMorgan